Cardiac resynchronization therapy: A review of CRT-D versus CRT-P

Future Cardiology

Volumn 5, Issue 6, 2009, Pages 567-572

  Stabile, Giuseppe ^a   Iuliano, Assunta ^b   Turco, Pietro ^a   Ciardiello, Carmine ^c   De Simone, Antonio ^d  

^a Clinica San Michele   (Italy)

^b Clinica Mediterranea   (Italy)

^c Boston Scientific   (Italy)

^d Casa di Cura San Michele Maddaloni ^*  (Italy)

Author keywords

Cardiac resynchronization; Guidelines; Implantable cardioverter defibrillator

Indexed keywords

CARDIAC RESYNCHRONIZATION DEFIBRILLATOR; CARDIAC RESYNCHRONIZATION PACER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR EQUIPMENT; CLINICAL TRIAL; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; FUNCTIONAL STATUS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SUDDEN DEATH; SURVIVAL RATE;

CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; EVIDENCE-BASED MEDICINE; HEART FAILURE; HUMANS; PACEMAKER, ARTIFICIAL; PROGNOSIS; QUALITY OF LIFE; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 74049122790     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.09.45     Document Type: Review

References (38)

1. Davies M, Hobbs F, Davis R et al.: Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening Study: a population based study. Lancet 358, 439-444 (2001).
2. McMurray JJ, Stewart S: Epidemiology, aetiology, and prognosis of heart failure. Heart 83, 596-602 (2000).
3. Cazeau S, Leclercq C, Lavergne T et al.: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay (MUSTIC SR). N. Engl. J. M Ed. 344, 873-880 (2001).
4. Abraham W T, Fisher WG, Smith AL et al.: For the MIRACLE Study Group: cardiac resynchronization in chronic heart failure. N. Engl. J. M Ed. 346, 1845-1853 (2002).
5. Young JB, Abraham WT, Smith AL et al.; The Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) Trial Investigators: Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 289, 2685-2694 (2003).
6. Higgins SL, Hummel JD, Niazi IK et al.: Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J. Am. Coll. Cardiol. 42, 1454-1459 (2003).
7. Abraham W T, Young JB, Leon AR et al.; Multicenter InSync ICD II Study Group: Effects of cardiac resynchronization on disease progression in patients with left ventricular dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic heart failure. Circulation 110, 2864-2868 (2004).
8. Bristow MR, Saxon LA, Boehmer J et al.; Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators: Cardiac resynchronization therapy with or without implantable defibrillator in advanced chronic heart failure. N. Engl. J. M Ed. 350, 2140-2150 (2004).
9. Cleland JG, Daubert JC, Erdmann E et al.; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. M Ed. 352, 1539-1549 (2005).
10. Cleland JG, Daubert JC, Erdmann E et al.: Long-term effects of cardiac resynchronization therapy on mortality in heart failure [The Cardiac Resynchronization - Heart Failure (CARE-HF) trial extension phase]. Eur. Heart J. 27, 1928-1932 (2006). ■Long-term effect of cardiac resynchronization therapy (CRT) on mortality.
11. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group: Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptom. J. Am. Coll. Cardiol. 52, 1834-1843 (2008).
12. Yu CM, Bleeker GB, Fung JW et al.: Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 112, 1580-1586 (2005).
13. Rivero-Ayerza M, Theunus DA, Gracia-Garcia HM, Boersma E, Simoons M, Jordaens LJ: Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur. Heart J. 27, 2682-2688 (2006).
14. McAlister FA, Ezekowitz J, Hooton N et al.: Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction. JAMA 297, 2502-2514 (2007).
15. Epstein AE, DiMarco JP, Ellenbogen KA et al.: ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 51, E1-E62 (2008). ■ American guidelines for implantation of cardiac pacemakers and antiarrhythmia devices.
16. Dickstein K, Cohen-Solal A, Filippatos G et al.: The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology: developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J. 29, 2388-2442 (2008). ■ European guidelines for treatment of heart failure.
17. Moss AJ, Hall WJ, Cannom DS et al.: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N. Engl. J. M Ed. 335, 1933-1940 (1996).
18. Buxton AB, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafey G: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N. Engl. J. M Ed. 341, 1882-1890 (1999).
19. Moss AJ, Zareba W, Hall WJ et al.: The multicenter autonomic defibrillator implantation trial II investigators: prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. M Ed. 346, 877-883 (2002).
20. Bardy GH, Lee KL, Mark DB et al.; The Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amioradone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. M Ed. 352, 225-237 (2005).
21. Desai AS, Fang JC, Maisel WH, Baughman KL: Implantable defibrillators for the prevention of mortality in patients with nonischemic dilated cardiomyopathy. N. Engl. J. M Ed. 292, 2874-2879 (2004).
22. Lam SKH, Owen A: Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials. BMJ 335, 925 (2007). ■■ Meta- analysis of studies on CRT and implantable cardioverter- defibrillator.
23. Higgins SL, Hummel JD, Niazi IK et al.: Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J. Am. Coll. Cardiol. 42, 1454-1459 (2003).
24. Abraham WT, Young JB, León AR et al.: Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter- defibrillator, and mildly symptomatic chronic heart failure. Multicenter InSync ICD II Study Group. Circulation 110 (18), 2864-2868 (2004).
25. Strickberger SA, Hummel JD, Bartlett TG et al.: Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT. AMIOVIRT Investigators. J. Am. Coll. Cardiol. 41 (10), 1707-1712 (2003).
26. Bansch D, Antz M, Boczor S et al.: Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 105, 1453-1458 (2002).
27. Kadish A, Dyer A, Daubert JP et al.: Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. N. Engl. J. M Ed. 350, 2151-2158 (2004).
28. Fox M, Mealing S, Anderson R et al.: The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model. Health Technol. Assess. 11 (47) (2007).
29. Auricchio A, Metra M, Gasparini M et al.: Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy. Multicenter Longitudinal Observational Study (MILOS) Group. Am. J. Cardiol. 99, 232-238 (2007). ■ Observational study on long-term outcome of CRT-pacer (CRT-P) and CRT pacer with defibrillator (CRT-D).
30. Stabile G, Solimene F, Bertaglia E et al.: Long-term outcomes of CRT-PM versus CRT-D recipients. PACE 32, S141-S145 (2009). ■ Observational study on long-term outcome of CRT-P and CRT-D.
31. Hunt SA, Abraham WT, Chin MH et al.: 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 53, E1-E90 (2009).
32. Feldman AM, de Lissovoy G, Bristow MR et al.: Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. J. Am. Coll. Cardiol. 46, 2311-2321 (2005).
33. Calvert MJ, Freemantle N, Yao G et al.: Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. Eur. Heart J. 26, 2681-2688 (2005).
34. Buxton AE, Lee KL, Hafley GE et al.: Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease. MUSTT Investigators. J. Am. Coll. Cardiol. 50, 1150-1157 (2007).
35. Cygankiewicz I, Gillespie J, Zareba W et al.: Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators. MADIT II Investigators. Heart Rhythm 6, 468-473 (2009).
36. Healey JS, Hallstrom AP, Kuck KH et al.: Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur. Heart J. 28, 1746-1749 (2007).
37. Epstein AE, Kay GN, Plumb VJ et al.: Implantable cardioverter-defibrillator prescription in the elderly. ACT Investigators. Heart Rhythm 6, 1136-1143 (2009).
38. Bruch C, Bruch C, Sindermann J, Breithardt G, Gradaus R: Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter-defibrillator. Europace 9, 681-686 (2007).